Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.

The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.

Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.

A growing number of consumers are seeking out third spaces and membership clubs surrounding wellness, to improve their health while also socializing.

Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.